Success Metrics

Clinical Success Rate

100.0%

Based on 5 completed trials

Completion Rate

100%(5/5)

Active Trials

1(14%)

Results Posted

20%(1 trials)

Phase Distribution

Ph not_applicable

57%

Ph phase_2

14%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 2Efficacy & side effects

1(20.0%)

N/ANon-phased studies

4(80.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(5)

Other(1)

Detailed Status

Completed5

unknown1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 21 (20.0%)

N/A4 (80.0%)

Trials by Status

completed571%

unknown114%

recruiting114%

Recent Activity

1 active trials

Showing 5 of 7

completednot_applicable

Clinical Trials (7)

Showing 7 of 7 trials

NCT06418152Not Applicable

Dual-task Augmented Reality for PD DBS

Completed

NCT07092332Not Applicable

Young Vulvodynia: Effect and Efficacy of Multimodal Treatment.

Recruiting

NCT06967233

Multimodal Managements for Metastatic Pancreatic Cancer.

Completed

NCT05184413Not Applicable

Telerehabilitation in Carpal Tunnel Syndrome

Completed

NCT05111873

Effects of Multimodal Treatment of Headache in a Day Clinic Service

Unknown

NCT01767246Not Applicable

The Evaluation of a Novel Treatment Algorithm for Patients With Patellofemoral Syndrome

Completed

NCT01379482Phase 2

Neo-adjuvant Chemo + Peritonectomy + Hyperthermic Intraperitoneal Chemo in Peritoneal Carcinomatosis From Gastric Cancer

Completed

All 7 trials loaded

Drug Details

Intervention Type: BEHAVIORAL
Total Trials: 7